Please login to the form below

Not currently logged in
Email:
Password:

Evotec enters new alliance with Genentech

Evotec and Genentech have formed a new integrated drug discovery alliance to support research into novel small molecule therapeutics

Evotec has announced today that it has formed a new alliance with Genentech (owned by Roche) to support Genentech's research to discover novel small molecule therapeutics.

Said Dr Werner Lanthaler, Evotec's CEO: "We are proud that Genentech, one of the premier biopharmaceutical companies worldwide, has selected Evotec's scientists and innovative drug discovery platform to support its research efforts. We look forward to working closely with Genentech's scientists and achieving success together."

The collaboration includes assay development and high throughput screening, medicinal chemistry and structural biology. Terms for the collaboration have not been disclosed.

Roche (one of several pharma companies working jointly with Evotec to develop its pipeline of products) already has several collaborative research areas in place, including one for product development in treatment-resistant depression and another to jointly discover and develop compounds against a target for CNS diseases and other indications.

Evotec is due to report its financial/performance results for the first quarter of 2010 on Wednesday May 12.

10th May 2010

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...
Data security
Concerns about data security are building a strong case for clinical mobility in EMEA
Electronic medical records have transformed the storage of sensitive information but how can the healthcare sector continue to protect patient and staff data?...
Mainimage2
The role of digital health technology tools in supporting medical adherence
How DHT-based digital interventions can help to support patients and improve adherence...